Genesis Molecular AI · 1 day ago
Software Engineer - Core Infrastructure
Genesis Therapeutics is building a world-class computational team to solve problems in drug discovery through machine learning, biophysical simulation, and computational chemistry. They are looking for an Infrastructure Engineer to maintain and grow their multi-cloud compute infrastructure that supports ML model training and drug discovery efforts.
Artificial Intelligence (AI)BiotechnologyInformation Technology
Responsibilities
Work on our infrastructure team to maintain and grow our multi-cloud compute infrastructure that supports our ML model training, computational chemistry research, and ongoing drug discovery efforts
Build out our configuration and procedures for monitoring, resource allocation, and deployment automation, as we continue to grow our autoscaling compute clusters to handle larger workloads
Work on orchestration scheduling framework to increase our execution throughput, reliability, and compute utilization across heterogeneous pipelines
Qualification
Required
5+ years of experience building and maintaining cloud infrastructure at scale, e.g. within AWS or GCP
Proficient with Python, Bash, Terraform, Ray and Kubernetes
Experience building and maintaining compute clusters running distributed ML training jobs with 1,000+ GPUs
Preferred
Hands-on experience with physical hardware + datacenter management
Benefits
Medical, dental, and vision insurance
401(k) program
Company
Genesis Molecular AI
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
H1B Sponsorship
Genesis Molecular AI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (1)
2023 (1)
2022 (1)
Funding
Current Stage
Growth StageTotal Funding
$256.1MKey Investors
Andreessen HorowitzRock Springs Capital
2023-08-21Series B· $200M
2020-12-02Series A· $52M
2020-04-01Series Unknown
Recent News
Genetic Engineering News
2025-12-10
MIT Technology Review
2025-11-27
Company data provided by crunchbase